Kynam Capital Management, LP Portfolio Holdings
Kynam Capital Management, LP
- $1.18 Billion
- Q3 2025
Kynam Capital Management, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.18 Billion distributed in 35 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Celldex Therapeutics, Inc. with a value of $158M, Syndax Pharmaceuticals Inc with a value of $131M, Vera Therapeutics, Inc. with a value of $117M, Cogent Biosciences, Inc. with a value of $113M, and Vaxcyte, Inc. with a value of $111M.
Examining the 13F form we can see an increase of $346M in the current position value, from $837M to 1.18B.
Kynam Capital Management, LP is based out at Princeton, NJ
Below you can find more details about Kynam Capital Management, LP portfolio as well as his latest detailed transactions.